Upvote
Downvote
Emory Pediatric Hematology Section Chief
Share Job
- Suggest Revision
Full-time
- The Hematology Program is the largest in the country in clinical volumes, with vigorous laboratory and clinical research in sickle cell disease, hemostasis and thrombosis, as well as general hematology, which encompasses red blood cell disorders and rare anemias, thalassemia, platelet disorders, bone marrow failure, immunohematogy, and vascular anomalies.
- About the Aflac Cancer & Blood Disorders CenterThe successful candidate will join one of the country's most robust pediatric hematology/oncology programs.
- The Aflac Cancer & Blood Disorders Center has 122 faculty and 50 Advance Practice Providers (APPs), conducting basic, translational, and clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR T-cell therapies, hemoglobinopathies, hemophilia and rare blood disorders.
- We follow over 2,100 active patients with sickle cell disease, and 600 with bleeding or clotting disorders.
- In 2022, Aflac faculty generated $43.3M in extramural funding, including more than $27.7M from the NIH.
Active Job
Updated 6 days agoSimilar Job
Relevance
Active